These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24315367)

  • 1. Does reduced creatine synthesis protect against statin myopathy?
    Ballard KD; Thompson PD
    Cell Metab; 2013 Dec; 18(6):773-4. PubMed ID: 24315367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATM gene variants and statin myopathy risk.
    Carr DF; Alfirevic A; Johnson R; Chinoy H; van Staa T; Pirmohamed M
    Nature; 2014 Sep; 513(7518):E1. PubMed ID: 25230669
    [No Abstract]   [Full Text] [Related]  

  • 3. A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.
    Mangravite LM; Engelhardt BE; Medina MW; Smith JD; Brown CD; Chasman DI; Mecham BH; Howie B; Shim H; Naidoo D; Feng Q; Rieder MJ; Chen YD; Rotter JI; Ridker PM; Hopewell JC; Parish S; Armitage J; Collins R; Wilke RA; Nickerson DA; Stephens M; Krauss RM
    Nature; 2013 Oct; 502(7471):377-80. PubMed ID: 23995691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mangravite et al. reply.
    Mangravite LM; Engelhardt BE; Stephens M; Krauss RM
    Nature; 2014 Sep; 513(7518):E3. PubMed ID: 25230670
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression quantitative trait locus analysis identifies novel genes for statin myopathy.
    Voora D
    Circ Cardiovasc Genet; 2014 Apr; 7(2):220-1. PubMed ID: 24736853
    [No Abstract]   [Full Text] [Related]  

  • 6. GATM locus does not replicate in rhabdomyolysis study.
    Floyd JS; Bis JC; Brody JA; Heckbert SR; Rice K; Psaty BM
    Nature; 2014 Sep; 513(7518):E1-3. PubMed ID: 25230668
    [No Abstract]   [Full Text] [Related]  

  • 7. The association of GATM polymorphism with statin-induced myopathy: a systematic review and meta-analysis.
    Liu M; Fan F; Zhang Y; Li J
    Eur J Clin Pharmacol; 2021 Mar; 77(3):349-357. PubMed ID: 33051696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals.
    Luzum JA; Kitzmiller JP; Isackson PJ; Ma C; Medina MW; Dauki AM; Mikulik EB; Ochs-Balcom HM; Vladutiu GD
    Cell Metab; 2015 Apr; 21(4):622-7. PubMed ID: 25863251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis.
    Xiang Q; Zhang XD; Mu GY; Wang Z; Liu ZY; Xie QF; Hu K; Zhang Z; Ma LY; Jiang J; Cui YM
    Eur J Clin Pharmacol; 2021 Apr; 77(4):569-581. PubMed ID: 33150478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review.
    Canestaro WJ; Austin MA; Thummel KE
    Genet Med; 2014 Nov; 16(11):810-9. PubMed ID: 24810685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Creatine kinase increase under simvastatin--therapeutic consequences?].
    Rasche-Schürmann CC; Picksak G; Stichtenoth DO
    Med Monatsschr Pharm; 2008 Jan; 31(1):25-7. PubMed ID: 18522017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLCO1B1 variants and statin-induced myopathy--a genomewide study.
    ; Link E; Parish S; Armitage J; Bowman L; Heath S; Matsuda F; Gut I; Lathrop M; Collins R
    N Engl J Med; 2008 Aug; 359(8):789-99. PubMed ID: 18650507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk: A Meta-Analysis of Case-Control Studies.
    Hou Q; Li S; Li L; Li Y; Sun X; Tian H
    Medicine (Baltimore); 2015 Sep; 94(37):e1268. PubMed ID: 26376374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLCO1B1 variants and statin-induced myopathy.
    Vladutiu GD; Isackson PJ
    N Engl J Med; 2009 Jan; 360(3):304. PubMed ID: 19144951
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
    Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
    Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathy.
    Kelsey MD; Newby LK
    Ann Intern Med; 2020 Dec; 173(12):JC71. PubMed ID: 33316194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin myopathy: a lipid clinic experience on the tolerability of statin rechallenge.
    Fung EC; Crook MA
    Cardiovasc Ther; 2012 Oct; 30(5):e212-8. PubMed ID: 21884002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interindividual differences in the response to statin therapy and gene polymorphisms related to myopathy during statin therapy].
    Dendramis G
    G Ital Cardiol (Rome); 2011 Mar; 12(3):182-5. PubMed ID: 21560474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of 160 cases of statin-induced myopathy].
    Jiang Y; Lou Y; Liu Y; Wang L; Pang H; Zhang J; Zhou Y; Li Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Nov; 42(11):905-9. PubMed ID: 25620251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatine, guanidinoacetate and homoarginine in statin-induced myopathy.
    Neu A; Hornig S; Sasani A; Isbrandt D; Gerloff C; Tsikas D; Schwedhelm E; Choe CU
    Amino Acids; 2020 Jul; 52(6-7):1067-1069. PubMed ID: 32594255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.